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Abstract Understanding biological processes assumes a
detailed understanding of the interaction of all involved
molecules. Here the effect of the peptide hormone angio-
tensin II (Ang II), an agonist of the angiotensin receptors,
on the structure of unilamellar and multilamellar dimyri-
stoyl phosphatidylcholine vesicles was studied by small
angle neutron scattering, dynamic light scattering and dif-
ferential scanning calorimetry. The calorimetry data indi-
cate a weak interaction of Ang II with the surface of the
membrane bilayer, as the pretransition persists during all
experiments, and the main transition is only slightly shifted
towards higher temperatures. From the SANS data we were
able to confirm the calorimetric data and verify the inter-
action of the hormone with the membrane surface. At low
temperatures, when the lipid molecules are in the gel phase,
more precisely in the ripple phase, the peptide penetrates in
the head group core, but due to the close packing of the
acyl chains, the hydrophobic region is not affected. In a
temperature region below but close to the region of the
phase transition, the hydrophibic core starts to be affected
by the peptide, and the same is true for the fluid phase.
Upon binding of the peptide, the thickness of the head
group increases, and the scattering length density of the
head group starts to rise with increasing peptide concen-
trations. This interaction and binding to the membrane
surface may be relevant for the relocation, binding and
reconstitution of the angiotensin receptors into the mem-
brane. Second, the peptide adsorption to the membrane
surface may contribute to the binding of Ang II in the
active site of the receptor.
Keywords Peptide-lipid interaction  Small angle neutron
scattering  Angiotensin II  DMPC  Model membranes 
Hypertension
Introduction
Hypertension is a growing problem worldwide, especially
in the Western world. It is one of the major controllable
risk factors associated with cardiovascular disease events
such as myocardial infarcation, heart failure and end-stage
diabetes (Pachori et al. 2001; De´zsi 2000; Labinjoh et al.
2000; Dimsdale et al. 1996; Neutel et al. 1999; MacMahon
et al. 1990; WHO 2003).
In mammals, the blood pressure is regulated by the
renin-angiotensin system, which plays a critical role in
circulatory homeostasis. Part of this system is the peptide
hormone angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-
Phe), a potent vasoconstrictor that aids in blood pressure
regulation as well as in body fluid balance maintenance.
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Ang II is derived from the precursor angiotensinogen by an
enzymatic reaction catalyzed by renin and the angiotensin
converting enzyme (ACE). In the heart, acting in both
endocrine and paracrine fashion, Ang II regulates con-
tractility, remodeling, growth and apoptosis, and reduces
cell coupling and conduction velocity in cardiac muscles.
The peptide acts on two major receptor subtypes, the Ang
II type 1 receptor (AT1 receptor) and the Ang II type 2
receptor (AT2 receptor). Although both types of receptors
were found in cardiac muscle cells, only the AT1 receptor
was found to mediate classical cardiovascular functions
like blood pressure elevation, vasoconstriction, aldosterone
release, and renal absorption of water and sodium. From a
pathophysiological point of view, like in renal diseases or
hypertension, changes in the renin-angiotensin system
occurred (Hong et al. 2008).
The role of Ang II in causing chronic diseases has been
discussed in several publications (Ruiz-Ortega et al. 2003;
Striker et al. 2008; Taylor 1999; de Gasparo et al. 2000).
ACE inhibitors and AT1 receptor antagonists influence the
cardiovascular status, demonstrating the important role of
the renin-angiotensin system in physiological and patho-
physiological states (Costerousse et al. 1992; Kurdi et al.
2005; NIH 2003). The inhibition of these enzymes (ACE)
or AT1 receptors is believed to lower blood pressure. At
present, the renin-angiotensin system has become a key
target for drugs combating hypertension (Hong et al.
2008).
Hypertension can be treated by b-blockers, inhibiting
the conversion of angiotensinogen to angiotensin I, or by
specific inhibition of the AT1 receptor by an Ang II
antagonist like Losartan with its active derivate E-3174.
Apart from action on the membrane-bound receptor, an in
vitro binding to lipids was described for Ang II, as well as
Losartan. It was shown by 1H-NMR that the binding of
Ang II depends on the pH of the surrounding medium and
the temperature. Several amino acids of the peptide are
involved in the binding to lipids (Valensin et al. 1986).
Later, DSC and 31P-NMR were used to further characterize
the interaction of DPPC with Ang II (Mavromoustakos
et al. 1996). The phase behavior of the DPPC is affected by
Ang II, as the main transition is shifted towards higher
temperatures and the pre-transition is broadened.
Unfortunately, only little is known about the lipid
environment the receptor is facing in vivo, especially if
considering the changing lipid composition with respect to
the tissue and the proliferation state. Moreover, lipid rafts,
clathrin-coated pits and caveolae play an important role in
the regulation of GPCRs (Chini and Parenti 2004). After
syntheses in the endoplasmatic reticulum and glycosyla-
tion, the receptors are sorted to the plasma membrane
(Leclerc et al. 2002; Wyse et al. 2003). Translocation into
lipid rafts is often accompanied by agonist binding. Here,
we demonstrate the binding of Ang II, an agonist of the AT
receptors, on the example of phospholipid membranes
using DMPC. With the main transition occurring at around
24C, it is possible to study the interaction in the gel
respectively ripple phase, and fluid phase of the lipid
without facing the problem of peptide degradation,
which means the temperature-dependent destruction of the
peptide.
To achieve a more complete view of the role of Ang II
in blood pressure regulation, SANS, DSC and DLS were
applied to study the interaction of the peptide Ang II with
model membranes. DSC is a versatile tool in life science,
allowing study of the thermotropic properties of a variety
of materials and model systems (Bruylants et al. 2005).
Especially for the study of membrane properties and
changes, calorimetric techniques are a vital tool (Westh
2009). DSC was applied to study drug-lipid interactions as
shown for vinorelbine (Koukoulitsa et al. 2006), malatonin
(Severcan et al. 2005) and the calcium-dependent antibi-
otic daptomycin (Jung et al. 2008). Work performed with
peptide-lipid interaction focuses on synthetic peptides
and peptides with antimicrobial properties; examples are
aurein, citropin and maculatin (Seto et al. 2007), maganin
(Ludtke et al. 1996), PGLa (Pabst et al. 2008) and other
cell-penetrating peptides (Alves et al. 2008).
SANS is a powerful technique to learn about the struc-
ture of a variety of materials. Basically all biological
macromolecules and the interaction among them can
be studied by SANS. Single proteins and complexes
(Petoukhov and Svergun 2006; Svergun and Koch 2003) as
well as polysaccharides like cyclodextrins (Burckbuchler
et al. 2008) are studied (Wang et al. 2009). A variety of
studies have dealt with lipids, their phases (Mason et al.
1999; Winter 2002) and the interaction with other classes
of molecules. Bacterial membranes were used as sources
(Mariani et al. 1997), but the majority of studies used
synthetic lipids as a model system (Kucerka et al. 2007,
2008; Nagle and Tristram-Nagle 2000).
So far, bilayer thickness and interface areas have been
studied (Balgavy´ et al. 2001; Pencer and Hallett 2000), as
well as the multilamelarity, structure and hydration of
different lipid systems (Schmiedel et al. 2006; Tung et al.
2008). In addition, contrast variation is a powerful tool to
trace changes occurring upon mixing of different lipids
(Knoll et al. 1981), such as changes in the bilayer thickness
as a response to the addition of sterols (Pencer et al. 2005;
Gallova´ et al. 2008; Kucerka et al. 2009), domain forma-
tion and rafts (Jacobson et al. 2007; Pencer et al. 2005).
The interaction of peptides and membranes was studied
in combination with studies on cytotoxicity, like in the case
of mellitin (Lundquist et al. 2008), and the development of
new antimicrobial drugs (Huang 2000; Han et al. 2009). So
far, no studies have been undertaken trying to study the
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interaction of peptides with membranes that do not lead to
the formation of pores. Here, we show that it is possible to
study the interaction of peptides with the membrane, even
if the interaction does not disrupt the bilayer structure, but
is based on a concentration-dependent adsorption process.
In addition to the SANS experiments, DLS experiments
were performed. The light scattering provided a first insight
into changes in the hydrodynamic radius upon addition of
the peptide in comparison to a pure DMPC sample. The
resulting hydrodynamic radius was used for the data fitting
of the SANS studies.
Methods
Materials
1,2-Dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC)
and the corresponding lipid with deuterated chains 1,2-
dimyristoyl-(d54)-sn-glycero-phosphocholine (d54-DMPC)
were purchased from Avanti Polar Lipids, Inc. (Alabaster,
AL). (4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid
sodium salt, (HEPES 99:5% pure), angiotensin II (human
actetat, 93% pure), NaCl (analytical grade) and D2O (99:9%
deuteration) were from Sigma-Aldrich. All chemicals were
used without further purification.
Differential scanning calorimetry
DSC experiments were performed on a high sensitivity dif-
ferential scanning calorimeter (Microcal VP-DSC, North-
ampton, MA), with a cell volume of 0.51 ml. The reference
cell contained pure water, and the heating rate was 5C/h. At
least two calorimetric scans were performed with each sample
to test reproducibility. Data evaluation was performed using a
macro running with Igor Pro (WaveMetrics, Inc., Portland,
OR). The raw data were normalized by the lipid concentration,
and the baseline was substracted. The phase transition tem-
peratures were taken at peak values of the heat capacity, cp,
and the calorimetric enthalpy DH was calculated by inte-
grating the peak areas. In addition, the position and area under
the pre-transition peak were determined.
Dynamic light scattering
For the light scattering experiments, an ALV-5000 Multi-
ple Tau Digital Correlator together with a HeNe-Laser at a
wavelength of 632.8 nm was used. The temperature was
controlled with an external heating circulator (F25-ME,
Julabo, Seelbach, Germany). For aqueous solutions, a
refractive index of 1.3320 was assumed, and the values for
the viscosity varied according to the temperature change.
The hydrodynamic radius was calculated as
Rh ¼ kT
6pgC
q2 ð1Þ
with
q ¼ 4pnsinð
h
2
Þ
k
ð2Þ
n as the refractive index, k the wavelength, h the scattering
angle, k Boltzmann’s constant, g the solvent viscosity and
C the average decay rate.
Small angle neutron scattering
For the SANS experiments a HEPES buffer (10 mM
HEPES, 100 mM NaCl) in D2O was used, applying the
concept of contrast variation (Knoll et al. 1981). Using
heavy water the pD was adjusted to a value equivalent to
pH 7.6 using the conversion pD = 0.929 pH meter reading
?0.42 (Lowe and Smith 1973). Ang II was added to the
buffer to final concentrations of 0.1, 0.5 and 1 mM. As a
control, a pure lipid sample was used.
Small-angle neutron scattering experiments were per-
formed on the SANS 1 instrument at the FRG 1 research
reactor at Helmholtz-Zentrum Geesthacht Centre for
Materials and Coastal Research, Germany (Stuhrmann
et al. 1995). The neutron wavelength was 8.5 A˚, and the
wavelength resolution was 10% (full width at half-maxi-
mum value). The range of scattering vectors (0:004 \ q \
0:25 A˚
1
) was obtained using four sample-to-detector dis-
tances from 0.7 to 9.7 m. For the SANS measurements, the
samples were equilibrated at various temperatures with a
precision of  0:5C in quartz cuvettes (Hellma, Muell-
heim, Germany) with a 1-mm path length. The raw SANS
spectra were corrected for backgrounds from the solvent,
sample cell and other sources by conventional procedures.
The two-dimensional isotropic scattering spectra were
averaged, normalized to the scattering of pure H2O; and
corrected for detector efficiency. Incoherent scattering of
the buffer was subtracted.
Vesicle preparation
For the DLS and SANS experiments, unilamellar vesicles
were used. DMPC respectively d54-DMPC was immersed
in the different buffers to a final concentration of 5 mM for
DLS and 10 mM for SANS, producing multilamellar ves-
icles (MLVs). The temperature of the dispersion was kept
above 40C, and, after vortexing, unilamellar extruded
vesicles were produced using an Avanti Mini Extruder
(Avanti Polar Lipids, Alabaster, AL) and an Isopore
polycarbonate filter (Millipore, Billerica, MA) of 0.1 lm
pore size. As extruded ULVs are generally contaminated
with pauci-lamellar vesicles (PLVs), a small vesicle size
Eur Biophys J (2011) 40:687–698 689
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was used to maximize the amount of ULVs (Kucerka et al.
2007). The MLVs were extruded an odd number of passes
to avoid contamination of the sample by large and multi-
lamellar vesicles, which might not have passed through the
filter.
SANS data analysis
The analysis of the SANS data was performed using the
software package described by Kline (2006) based on
macros running under Igor Pro (WaveMetrics, Inc., Port-
land, OR). This data analysis software provides the possi-
bilty to carry out non-linear data fitting, based on a variety
of included form factors. To analyze our data in particular,
the combination of form factors became necessary. Fol-
lowing the separated form factor approach as published by
Kiselev et al. (2002), two form factors were summed up in
order to reflect the changes in the sample with an appropriate
model. One of the two form factors describes a lamellae,
taking into account different scattering length densities for the
chain and the head group region (Nallet et al. 1993; Javierre
et al. 2000). Second, a form factor representing a polydisperse
vesicle (Bartlett and Ottewill 1992) was used. The initially
used scattering length densities (SLDs) were calculated val-
ues. The scattering length values for D2O were fixed. For the
bilayer thickness, the length of the head group and the
hydrophobic region of pure DMPC literature values were used
as an orientation (Nagle and Tristram-Nagle 2000; Kucerka
et al. 2008; Kiselev et al. 2006).
Form factor of polydisperse vesicles
The form factor (FF) for a vesicle with a polydisperse core
with constant shell thickness was used as described by
Bartlett and Ottewill (1992). To derive the relation and to
define the parameters of the FF, a suspension of noninter-
acting particles was considered showing only coherent
scattering and no multiple scattering.
d
P
dx
ðqÞ ¼ n
X
iðvÞ
biexpðiq  riÞ












2* +
ð3Þ
bi is the atomic scattering length density, n is the number
density of particles, and the sum is added over all atoms in
the particle volume v. As SANS experiments do not yield
information on the atomic scale, the atomic scattering
lengths bi could be replaced by the locally averaged
scattering length density defined as
qðrÞ ¼
X
i
bidðr  riÞ ð4Þ
bi is the scattering length of the atom at the position ri.
Replacing the sum in Eq. 3 by an integral yields an
expression for the scattering from a suspension of
noninteracting spheres
dR
dx
ðqÞ ¼ nFðqÞ2 ð5Þ
where the scattering amplitude if defined by the Fourier
transform
FðqÞ ¼
Z
qðrÞ  qm½ expðiq  rÞdr ð6Þ
qm is the scattering length density of the buffer. Assuming
a spherically symmetric profile q(r), the scattering
amplitude for a single particle reduced to
FðqÞ ¼ 4p
Z
r2 qðrÞ  qm½ 
sin qr
qr
dr ð7Þ
The scattering profile has the form
qðrÞ ¼ qc r rc
qs rc\r rc þ D

ð8Þ
with rc the radius of the spherical core and the scattering
length density qc surrounded by a shell of the thickness D
with the scattering length density qs. Correspondingly, the
particle scattering amplitude could be written as
FðxÞ ¼ 4p
q3
ðqs  qcÞfcjðx þ dxÞ  jðxÞg ð9Þ
q ¼ D=rc and x = q rc. The function j(x) = sin x - x cos x.
The scaled medium contrast c ¼ ðqm  qsÞ=ðqc  qsÞ
determines the relative proportion of the scattering from the
core or the shell. To take into account the polydispersity of the
vesicle, a particle distribution was introduced. For this, Eq. 5
needed to be averaged over the particle size distribution,
assuming that only the size of the particle core varied, whereas
the shell thickness D was constant. For this the single particle
FF F2(qrc) was replaced by the size average
F2ðqrcÞ ¼
Z1
0
GðrcÞF2ðqrcÞdrc ð10Þ
G (rc) is the normalized probability to find a particle with a core
radius between rc, and rc þ drc; rc is the mean core radius. For
the distribution of the mean core radius, a Schulz distribution
was picked. The normalized form of this distribution is
GðrcÞ ¼ r
Z
c
CðZ þ 1Þ
Z þ 1
rc
 Zþ1
exp  rc
rc
ðZ þ 1Þ
 
ð11Þ
in which rc is the mean core radius, and Z is related to the
normalized polydispersity rc of the particle core radius
distribution
r2c ¼
r2c
r2c
 1
 
¼ 1
Z þ 1 ð12Þ
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Lamellar form factor
For the description of the bilayer, a lamellar FF was used as
published by Nallet et al. (1993) and Javierre et al. (2000).
To describe the different segments of the bilayer, a two-
square profile was defined, with two variable parameters
for each segment. The segments were the head group with
the thickness dH and the scattering length density rH, and
accordingly the tail with the thickness dT and the scattering
length density rT. To derive the form factor the following
assumptions were made
DrH ¼ rH  rsolvent ð13Þ
DrT ¼ rT  rH ð14Þ
2ðdH þ dTÞ ¼ total bilayer thickness ð15Þ
The resulting FF had the following format.
PðqÞ ¼ 4
q2
DqH sin qðqH þ qTÞ½   sinðqqTÞ½ f
þDqT sinðqdTÞg2 ð16Þ
Results
Differential scanning calorimetry
In the DSC measurements we investigated pure DMPC
samples and the same concentration of DMPC with dif-
ferent concentrations of Ang II. The data were normalized
by the lipid concentration, and the baseline was subtracted.
In Table 1 the thermodynamic data resulting from the DSC
scans are listed, and in Fig. 1 the corresponding thermo-
tropic traces are shown. The table comprises the values for
the peak temperatures of the pre- and main transition. In
addition, the enthalpy was calculated by integration of the
area under the main transition peak and the pre-transition
peak. Another indicator for changes in the phase behavior
is the upper phase boundary, representing the temperature
where half of the lipids are in the gel state and the other
half in the fluid state (Feigenson 2007).
The results for pure DMPC dispersions were in good
agreement with those of previous studies (Heimburg 2000).
For pure DMPC a sharp main transition peak just below
24C and in addition a pre-transition around 14C were
expected. From our measurement, a temperature of 23:6C
for the main transition and 13:8C for the pre-transition
resulted. Accordingly, the enthalpy for the main transition
was calculated as 6.55 and as 1.37 kJ/mol for the pre-
transition.
With increasing concentrations of Ang II, the peak
temperature shifted towards higher temperatures, and the
enthalpy increased. For the main transition, the enthalpy
increased constantly with increasing concentrations of the
peptide. The initial addition of the peptide led to an
increase in enthalpy of about 1.5 kJ/mol. At higher con-
centrations, a smaller increase in the enthalpy of the main
transition could be observed. For ever higher ratios, the
enthalpy increased by about 600 J/mol.
In addition, the enthalpy of the pre-transition changed
upon addition of the peptide. At the highest peptide:lipid
ratio (1:100), an increase of 72 J/mol was calculated. For
the peptide lipid ratio of 1:50, the enthalpy increased more
than 200 J/mol. Finally, for the peptide:lipid ratio of 1:10,
the enthalpy increased again by about 200 J/mol compared
to the previous ratio. For the highest concentration of the
peptide and a ratio of peptide to lipid of 1:5, the enthalpy of
the pre-transition dropped slightly compared to the next
lower peptide concentration.
Studying the temperature change induced by the pep-
tide, again the temperature of the main transition and of the
pre-transition was compared for pure DMPC and samples
containing Ang II in addition. The temperature of the main
transition shifted between 0:4 and 0:6C as a response to
Ang II binding. Comparing the temperature of the pure
DMPC sample and after addition of peptide with a pep-
tide:lipid ratio of 1:100, an increase in the transition
temperature of 0:4C was observed. For the higher peptide
concentrations, only a small further increase of the tem-
perature could be seen. The analysis of the pre-transition
temperature gave a similar result. The temperature
Table 1 Enthalpy and peak temperature of the main transition and pre-transition, as well as the upper phase boundary for pure DMPC
dispersions and DMPC mixed with Ang II in the peptide:lipid ratios 1:100, 1:50, 1:10 and 1:5
Sample DMPC 1:100 1:50 1:10 1:5
Enthalpy main transition
Cp ðJ=mol degÞ
6,558.6 ± 918.2 8,040.47 ± 1,225.66 8,818.38 ± 1,234.57 9,602.9 ± 1,344.4 10,361.4 ± 1,450.59
Pre-transition Cp ðJ=mol degÞ 1,374.09 ± 192.37 1,446.95 ± 202.573 1,645 ± 230.3 1,856.25 ± 259.87 1,765.54 ± 247.17
Peak temperature main
temperature (C)
23.59 23.99 24.01 24.04 24.03
Peak temperature
pre-temperature (C)
13.84 15.19 15.37 15.12 15.05
Upper phase boundary (C) 23.64 24.07 24.07 24.11 24.16
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increased by 1:3C for the addition of the peptide at the
lowest concentration and by around 0:2C for the next
higher peptide concentration. For the higher peptide concen-
trations, the result was different. The temperature always
stayed above 15C: Another indicator for changes occurring at
the membrane is the upper phase boundary, the temperature
where an equal number of lipids are in the fluid state and in the
gel state. For DMPC the upper phase boundary was calculated
as 23:64C, and it increased by 0:42C for the two lowest
peptide concentrations. For the two higher concentrations the
temperature increased by 0:46C:
As the pre-transition temperature is more sensitive to
changes at the membrane surface, a change in the pre-
transition temperature points to an interaction of the
peptide with the membrane surface. Upon molecules
interacting not only with the surface, but also at the
interface region or in the hydrophobic region, the pre-
transiton will vanish completely. For the present study, the
pretransition remained visible in the data and was shifted
towards higher temperatures by more than 1C: The peak
broadened, and the enthalpy increased.
The enthalpy of the main transition also increased
except at the highest peptide concentration. This non-linear
increase in enthalpy supported a weak binding and inter-
action with the surface of the bilayer. With a decreasing
peptide:lipid ratio, a saturation level was reached where no
further peptide molecules bound to the surface. We will
further elaborate on this fact after introducing the results
from the scattering experiments. The results from the DSC
gave a first insight into the interaction of the membrane
with the peptide, and it can be concluded that the interac-
tion was weak and mainly took place at the surface of the
membrane. Keeping in mind that calorimetric studies only
trace changes, having an impact on the enthalpy of the
system, not all structural changes could be recorded. To get
a more detailed view of the structural changes, small angle
scattering was applied.
Dynamic light scattering
Dynamic light scattering was used to gain a first insight
into the structural changes occurring in the vesicles upon
addition of the peptide; the results are shown in Fig. 2 and
Table 2. The main information gained from light scattering
experiments is the hydrodynamic radius. For the experi-
ments extruded vesicles were used, and the buffer con-
tained the peptide in different concentrations. As a main
result we could show that the hydrodynamic radius
decreases upon addition of the peptide. Initially, a hydro-
dynamic radius of about 85 nm was measured for DMPC
above the phase transition. Lowering the temperature led to
a gradual decrease in the hydrodynamic radius. Below the
phase transition the radius reached around 65 nm. The
difference in the radius can be explained by the melting of
the lipid acyl chains, increasing the area per lipid by about
30%.
BA
C
°
°°
Fig. 1 Excess heat capacity curves of DMPC and mixtures of peptide and lipid with ratios of 1:100, 1:50, 1:10 and 1:5. a Displays the whole
thermogram. b Shows a magnification of the pre-transition region and c a magnification of the main transition peaks
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Small angle neutron scattering
To gain an insight into the structural changes occurring on
the membrane level, small angle neutron scattering (SANS)
was applied. Diluted dispersions, containing about 1 w%
lipid, were used as sample material to ensure that only
single particle form factors (FFs) were measured. The
dispersion was extruded to avoid aggregation and periodic
packing of bilayers that could have given rise to Bragg
peaks. All samples were measured with respect to the
different lipid phases at 15; 22 and 35C.
After general corrections, averaging and integration of
the data, detailed data analysis was performed using the
separated form factor (SFF) approach (Kiselev et al. 2002).
Two FFs were combined, leading to the possibility to
describe the vesicle and the structure of the lamellae at the
same time. In detail, the first FF described the tail length
and the thickness of the head group and the corresponding
scattering length densities (SLDs), respectively. The sec-
ond FF was used to describe the overall structure of the
vesicle, taking into account the vesicle size, the bilayer
thickness and the polydispersity of the vesicle. For all
experiments, chain deuterated DMPC (d54-DMPC) was
used, having the advantage that a large SLD contrast dif-
ference exists between the head group and the acyl chains.
A penetration of the peptide into the hydrophobic core
would become visible instantly in the data. The results are
displayed in Fig. 3 and in Table 3 for the different
temperatures.
At first the data from the pure d54-DMPC samples were
fitted, starting with the data set where the lipids were in the
fluid state as only limited literature is available for the gel
respectively ripple phase. The values for d54-DMPC in the
fluid phase literature values were taken where possible or
the values for DPPC were used taking into account the
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Fig. 2 Dynamic light scattering data showing the hydrodynamic radii
calculated for temperatures between 5 and 35C. The bars indicate
the error resulting from the polydispersity of the vesicles. The line
between the data points is added to provide better visibility
Table 2 Hydrodynamic radii
from dynamic light scattering
experiments for pure DMPC
dispersions and lipid peptide
mixtures with different ratios
shown for temperatures between
35 and 5C
Temperature
(C)
Hydrodynamic radius (nm)
DMPC (1:100) (1:50) (1:10) (1:5)
35 84.72 ± 6.78 70.22 ± 5.62 70.93 ± 5.67 65.31 ± 5.22 65.78 ± 5.26
33 81.04 ± 6.48 67.17 ± 5.37 69.84 ± 5.59 63.75 ± 5.10 62.45 ± 5.00
31 79.98 ± 6.40 66.30 ± 5.30 69.10 ± 5.53 62.37 ± 4.99 62.13 ± 4.97
29 78.84 ± 6.31 65.35 ± 5.23 67.91 ± 5.43 61.48 ± 4.92 61.78 ± 4.94
27 78.10 ± 6.25 64.74 ± 5.18 65.46 ± 5.24 59.60 ± 4.77 60.25 ± 4.82
26 77.61 ± 6.21 64.33 ± 5.15 65.79 ± 5.26 60.35 ± 4.83 60.36 ± 4.83
25 78.70 ± 6.30 65.24 ± 5.22 67.15 ± 5.37 59.60 ± 4.77 60.17 ± 4.81
24 78.30 ± 6.26 64.91 ± 5.19 67.44 ± 5.40 59.92 ± 4.79 60.80 ± 4.86
23 78.93 ± 6.31 65.43 ± 5.23 65.80 ± 5.26 59.77 ± 4.78 60.42 ± 4.83
22 78.97 ± 6.32 65.46 ± 5.24 67.52 ± 5.40 59.71 ± 4.78 60.10 ± 4.81
21 77.96 ± 6.24 64.62 ± 5.17 66.12 ± 5.29 59.69 ± 4.78 59.21 ± 4.74
20 78.69 ± 6.29 65.22 ± 5.22 67.26 ± 5.38 59.08 ± 4.73 61.42 ± 4.91
19 79.91 ± 6.39 66.24 ± 5.30 66.03 ± 5.28 57.18 ± 4.57 58.54 ± 4.68
18 78.52 ± 6.28 65.09 ± 5.21 66.46 ± 5.32 57.72 ± 4.62 59.25 ± 4.74
16 76.75 ± 6.14 63.62 ± 5.09 64.84 ± 5.19 55.34 ± 4.43 56.24 ± 4.50
14 75.35 ± 6.03 62.46 ± 5.00 61.83 ± 4.95 55.25 ± 4.42 56.39 ± 4.51
12 73.75 ± 5.90 61.13 ± 4.89 59.75 ± 4.78 52.71 ± 4.22 54.56 ± 4.36
10 69.92 ± 5.59 57.96 ± 4.64 59.07 ± 4.73 51.45 ± 4.12 52.30 ± 4.18
8 69.57 ± 5.57 57.66 ± 4.61 56.08 ± 4.49 49.31 ± 3.95 51.06 ± 4.08
6 65.53 ± 5.24 54.32 ± 4.35 55.27 ± 4.42 48.14 ± 3.85 49.20 ± 3.94
5 63.50 ± 5.08 54.33 ± 4.35 48.13 ± 3.85 49.32 ± 3.95
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difference in tail length (Nagle and Tristram-Nagle 2000;
Kucerka et al. 2008; Kiselev et al. 2006). Based on this
initial data, a fit to the experimental data became possible.
For d54-DMPC in the fluid phase, the tail length was fitted
to 13.8 A˚ ± 1.65 A˚ with a SLD of 7:1  106 A˚2 and for
the head group a thickness of 5.47 ± 0.65 A˚ with a SLD of
1:83  106 A˚2 0.21 106 A˚2. This sums up to a
membrane thickness of 38.54 A˚, which is in good agree-
ment with the literature values (Kucerka et al. 2008;
Kiselev et al. 2006). With these parameters the according
fits for the d54-DMPC data sets at lower temperatures were
performed. For the sample at 15C, a smaller thickness of
the head group and a longer hydrophobic region was
expected. The head group was slightly tilted in the ripple
phase, and therefore the head group appeared smaller in the
ripple phase. Unmolten acyl chains are about 20% longer
than the molten ones, making a difference of about 3 A˚
between the two states. For the sample at 22C, the values
should lie in between. The resulting thickness of the head
group at 15C was 4 A˚ and 4.74 A˚ at 22C;; correspond-
ingly the tail length at 15C was fitted with 16. A˚ and for
22C with 14.5 A˚. Based on the fits for the pure lipid
samples, the data with increasing peptide:lipid ratios were
fitted. At 15C the acyl chains were fitted with a constant
length of 16:3 A˚  0:1:956 A˚: The thickness of the head
group increased with the amount of peptide added from
4 A˚  0:48 A˚ for pure d54-DMPC to 4:59 A˚  0:55 A˚ at a
peptide:lipid ratio of 1:100, 5.48 A˚ ± 0.657 A˚ at a pep-
tide:lipid ratio of 1:50 and finally to 7:76 A˚  0:93 A˚ at a
ratio of 1:10. The fits for the sample incubated at 22C
resulted in an slight decrease of the tail length, going from
14:5 A˚  1:74 A˚; 14:85 A˚  1:782 A˚ to 13:6 A˚  1:63 A˚
with increasing peptide concentration. In turn the head
group size increased from 4:64 A˚  0:808 A˚ over 6:12 A˚ 
0:734 A˚ and 7:67 A˚  0:92 A˚ to 7:4 A˚  0:88 A˚ for the
highest peptide amount in the sample. In the fluid phase, at
35C; the tail length again decreased slightly from 13.53
A˚ ± 1.623 A˚ (peptide:lipid ratio 1:100) to 13.4 A˚ ± 1.6 A˚
(1:50) down to 13 A˚ ± 1.5 A˚ (1:10). The fitted values for
the head group were 6 A˚  0:7 A˚; 6:65 A˚  0:798 A˚ and
8.6 A˚ ± 1.03 A˚ with increasing peptide:lipid ratio.
In addition to changes in the length of the head group
and the hydrophobic tail, the SLDs were adjusted during
the fitting procedure. At 15C the SLD for the head
group changed from 1:57  106 A˚2  0:188  106 A˚2
over 1:9  106 A˚2  0:22  106 A˚2 to 3:3  106 A˚2 
0:39  106 A˚2 and accordingly for the acyl chains drop-
ped slightly to 7:1  106 A˚2. At 22C the SLD of the head
group also increased with increasing amounts of peptides
by around 2  106 A˚2; whereas the SLD of the tails
stayed constant. Finally, for 35C the SLD of the head
group stayed constant for the low peptide concentrations,
but increased to 3:14  106 A˚2 for a peptide:lipid ratio of
1:10. The SLD of the tail decreased only insignificantly.
Discussion
From the results of the DSC and the SANS data, a con-
centration-dependent model for the binding of Ang II to
membranes can be suggested. The DSC experiments
resulted in a shift of the main transition towards higher
temperatures; hence, a preferential binding to the gel phase
was indicated. This was supported by the SANS data, as
the increase in head group thickness at 15C was the
highest one for all the studied temperatures, accompanied
by the highest increase in the SLD of the head group. The
thickness of the tail stayed unaffected, which can be
explained by the close packing of the acyl chains in the gel
phase, which could not be accessed by the peptide, even at
high peptide concentrations.
At 35C the head group thickness also increased upon
the binding of the peptide, and in addition the tail length
was slightly decreased, pointing to a penetration of the
peptide into the interface of the head group and the acyl
°
°
°
Fig. 3 Small angle scattering data and according fits. Data are shown
for experiments on pure d54-DMPC and mixtures of peptide and lipid
of 1:100, 1:50, 1:10 and 1:5. The lines indicate the fits performed for
the individual data sets
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chains. Close to the phase transition at 22C, this effect was
even more pronounced, as the membrane was most flexible
in this temperature region. This tendency was supported by
the corresponding changes in the SLDs. At all temperatures
the SLD of the tails stayed basically constant, whereas it
increased for the head group region. This increase in the
SLD was caused by the interaction of the peptide. The SLD
of the peptide was lower than that of the lipid head group,
but the penetration of D2O molecules into this region
caused an increase in the SLD. For the samples at 22C, the
SLD of the tails again stayed constant, and the one for the
head group increased. At 35C the SLD of the tails again
could be considered as constant, and the SLD of the head
only changed for high concentrations of peptides.
Our data give clear evidence for the adsorption of the
peptide to the membrane surface. A tendency for preferred
binding at the gel phase was evident, and only at high
concentrations did the peptide start to penetrate closer to
the interface between the head group and the acyl chains.
Looking at the previously published studies, it becomes
evident that they focus on the structure of the peptide in
different chemical environments. Various experiments
aimed to elucidate the peptide structure in the receptor,
which would lead to a basis for the rational design of Ang
II peptidomimetics with potent antagonist properties. So
far, no experimental structural information about the pep-
tide bound to the AT1 receptor is available, and therefore a
number of secondary structural features under various
conditions in attempts to mimic the natural environment of
the receptor have been analyzed (Surewicz and Mantsch
1988; Garcia et al. 1992; Shin and Yoo 1996; Cho and
Asher 1996; Joseph et al. 1995), and in vitro binding
studies of Losartan or Ang II have been made (Chansel
et al. 1994).
Table 3 Small angle neutron scattering data fitting parameter
Temp (C) Sample d54-DMPC 1:100 1:50 1:10
15 Tail length (A˚) 16 ± 1.9 16.3 ± 1.95 16.3 ± 1.95 16.3 ± 1.95
Head group thickness (A˚) 4 ± 0.4 4.59 ± 0.55 5.48 ± 0.657 7.76 ± 0.931
SLD tails (106 A˚2) 7.2 ± 0.85 7.2 ± 0.86 7.15 ± 0.85 7.1 ± 0.85
SLD head group (106 A˚2) 2.04 ± 0.244 1.57 ± 0.188 1.9 ± 0.22 3.3 ± 0.39
Background (cm-1) 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001
Average core radius (A˚) 760.5 ± 91.2 630.4 ± 75.6 633.3 ± 75.9 552.9 ± 66.3
Overall polydispersity 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033
SLD core and solvent (106 A˚2) 6.3 ± 0.756 6.36 ± 0.763 6.36 ± 0.763 6.36 ± 0.763
SLD shell (106 A˚2) 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573
22 Tail length (A˚) 14.5 ± 1.74 14.5 ± 1.74 14.85 ± 1.782 13.6 ± 1.632
Head group thickness (A˚) 4.74 ± 0.808 6.12 ± 0.734 7.67 ± 0.92 7.4 ± 0.88
SLD tails (106 A˚2) 7.2 ± 0.86 7.2 ± 0.86 7.1 ± 0.85 7.15 ± 0.85
SLD head group (106 A˚2) 2.09 ± 0.25 1.95 ± 0.234 1.65 ± 0.198 3.56 ± 0.427
Background (cm-1) 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001
Average core radius (A˚) 789 ± 94.6 650.8 ± 78.09 675.2 ± 81.02 597 ± 71.6
Overall polydispersity 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033
SLD core and solvent (106 A˚2) 6.36 ± 0.763 6.36 ± 0.763 6.36 ± 0.763 6.36 ± 0.763
SLD shell (106 A˚2) 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573
35 Tail length (A˚) 13.8 ± 1.65 13.53 ± 1.62 13.4 ± 1.6 13 ± 1.56
Head group thickness (A˚) 5.47 ± 0.656 6 ± 0.7 6.65 ± 0.798 8.6 ± 1.03
SLD tails (106 A˚2) 7.1 ± 0.85 7.1 ± 0.86 7.1 ± 0.85 7 ± 0.84
SLD head group (106 A˚2) 1.83 ± 0.219 1.79 ± 0.214 1.5 ± 0.18 3.14 ± 0.376
Background (cm-1) 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001 0.001 ± 0.0001
Average core radius (A˚) 847 ± 101.6 702.2 ± 84.26 709 ± 85.08 653 ± 78.36
Overall polydispersity 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033 0.28 ± 0.033
SLD core and solvent (106 A˚2) 6.36 ± 0.763 6.36 ± 0.763 6.36 ± 0.763 6.36 ± 0.763
SLD shell (106 A˚2) 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573 4.78 ± 0.573
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Fatigati and Peach postulated a lipid milieu as the local
environment for Ang II; therefore, our interest focused on the
concentration-dependent interaction of Ang II on model
membranes and the structural changes induced by the insertion,
studied at different temperatures (Fatigati and Peach 1988).
For the AT1 receptor antagonist Losartan binding is
facilitated by binding of the antagonist to the membrane
surface and diffusion through the membrane bilayer prior
to binding of the receptor (Zoumpoulakis et al. 2003).
Different from the mechanism proposed for Losartan, the
adsorption of Ang II to the membrane surface may be
involved in the translocation of the receptor. The binding
of Ang II to the membrane can facilitate the transfer of the
peptide to the active pocket in the receptor. Along with this
discussion, our study provides new insight into the inter-
action of Ang II with model membranes, in this case
DMPC vesicles. It can be concluded that Ang II influences
the hydration of the head group and that this facilitates the
insertion of the receptor in the membrane and subsequently
the activation of the receptor by the peptide.
Conclusion
In conclusion, we could show that Ang II is in interaction with
the surface of the membrane depending on the peptide con-
centration and the phase of the lipids. At low temperatures the
peptide stayed on the surface and in the head group region.
With increasing temperatures and increased fluctuations close
to the temperature of the phase transition, a deeper penetration
of the peptide into the bilayer is enabled. Ang II alters the
hydration of the lipid head groups, facilitating possible
refolding of the receptor in the membrane and the subsequent
binding of Ang II in the active site.
In addition, we showed here that SANS is a suitable tool
to study the interaction of a membrane-active peptide with
the lipid surface. Key is the data analysis, as the combi-
nation of separated form factors gives rise to a variety of
parameters that can describe a system on the level of the
lamellae up to changes in the overall vesicle size. SANS
and the method of contrast variation give rise to an increase
in contrast, enabling a label-free sample preparation. The
use of chain deuterated DMPC has the advantage that the
contrast between the head group and the acyl chains is
comparably high, such as the one between D2O and the
head group.
Acknowledgments This research project was supported by the
European Commission under the 6th Framework Programme through
the Key Action: Strengthening the European Research Area, Research
Infrastructures, contract no. RII3-CT-2003-505925. J.P. has been
supported by the European Commission under the 6th Framework
Programme through the Marie-Curie Action: BIOCONTROL, con-
tract no. MCRTN 33439. The authors would like to thank the staff of
the cSAXS group at the Paul Scherrer Institute for use of the light
scattering equipment
References
Alves ID, Goasdoue´ N, Correia I, Aubry S, Galanth C, Sagan S,
Lavielle S, Chassaing G (2008) Membrane interaction and
perturbation mechanisms induced by two cationic cell penetrat-
ing peptides with distinct charge distribution. BBA-Gen Sub
1780(7–8):948–959
Balgavy´ P, Dubnickova´ M, Kucerka N, Kiselev MA, Yaradaikin SP,
Uhrı´kova´ D (2001) Bilayer thickness and lipid interface area in
unilamellar extruded 1,2-diacylphosphatidylcholine liposomes: a
small-angle neutron scattering study. Biochim Biophys Acta
1512(1):40–52
Bartlett P, Ottewill R (1992) A neutron-scattering study of the structural
of a bimodal colloidal crystal. J Chem Phys 96(4):3306–3318
Bruylants G, Wouters J, Michaux C (2005) Differential scanning
calorimetry in life science: thermodynamics, stability, molecular
recognition and application in drug design. Curr Med Chem
12(17):2011–20
Burckbuchler V, Wintgens V, Leborgne C, Lecomte S, Leygue N,
Scherman D, Kichler A, Amiel C (2008) Development and
characterization of new cyclodextrin polymer-based dna delivery
systems. Bioconjug Chem 19(12):2311–2320
Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R
(1994) Differential regulation of angiotensin ii and losartan
binding sites in glomeruli and mesangial cells. Am J Physiol
266(3 Pt 2):F384–93
Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts
and caveolae: how, when and why do they go there? J Mol
Endocrinol 32:325–338
Cho NJ, Asher SA (1996) Uv resonance raman and absorption studies
of angiotensin ii conformation in lipid environments. Biospec-
troscopy 2(2):71–82
Costerousse O, Jaspard E, Wei L, Corvol P, Alhenc-Gelas F (1992)
The angiotensin i-converting enzyme (kininase ii): molecular
organization and regulation of its expression in humans.
J Cardiovasc Pharmacol 20(Suppl 9):S10–5
de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000)
International union of pharmacology. xxiii. the angiotensin ii
receptors. Pharmacol Rev 52(3):415–472
De´zsi L (2000) Fibrinolytic actions of ace inhibitors: a significant plus
beyond antihypertensive therapeutic effects. Cardiovasc Res
47(4):642–644
Dimsdale JE, Kolterman O, Koda J, Nelesen R (1996) Effect of race
and hypertension on plasma amylin concentrations. Hyperten-
sion 27(6):1273–1276
Fatigati V, Peach MJ (1988) Development of a new fluorescent
angiotensin ii probe. Am J Physiol 255(4 Pt 1):C452–C458
Feigenson GW (2007) Phase boundaries and biological membranes.
Annual Rev Biophys Biomol Struct 36:63–77
Gallova´ J, Uhrı´kova´ D, Kucerka N, Teixeira J, Balgavy´ P (2008)
Hydrophobic thickness, lipid surface area and polar region hydra-
tion in monounsaturated diacylphosphatidylcholine bilayers: Sans
study of effects of cholesterol and beta-sitosterol in unilamellar
vesicles. Biochim Biophys Acta 1778(11):2627–2632
Garcia KC, Ronco PM, Verroust PJ, Bru¨nger AT, Amzel LM (1992)
Three-dimensional structure of an angiotensin ii-fab complex at
3 a: hormone recognition by an anti-idiotypic antibody. Sci
Agric 257(5069):502–507
Han M, Mei Y, Khant H, Ludtke Steven J (2009) Characterization of
antibiotic peptide pores using cryo-em and comparison to
neutron scattering. Biophys J 97(1):164–172
696 Eur Biophys J (2011) 40:687–698
123
Heimburg T (2000) A model for the lipid pretransition: coupling of
ripple formation with the chain-melting transition. Biophys J
78(3):1154–1165
Hong F, Ming L, Yi S, Zhanxia L, Yongquan W, Chi L (2008) The
antihypertensive effect of peptides: a novel alternative to drugs?
Peptides 29(6):1062–1071
Huang HW (2000) Action of antimicrobial peptides: two-state model.
Biochem Cell Biol 39(29):8347–52
Jacobson K, Mouritsen O, Anderson R (2007) Lipid rafts: at a
crossroad between cell biology and physics. Nat Cell Biol
9(1):7–14. doi:10.1038/ncb0107-7
Javierre I, Nallet F, Bellocq AM, Maugey M (2000) Structure and
dynamic properties of a polymer-induced sponge phase. J Phys
Condens Matter 12:A295–A299
Joseph MP, Maigret B, Bonnafous JC, Marie J, Scheraga HA (1995)
A computer modeling postulated mechanism for angiotensin ii
receptor activation. J Protein Chem 14(5):381–98
Jung D, Powers JP, Straus SK, Hancock REW (2008) Lipid-specific
binding of the calcium-dependent antibiotic daptomycin leads to
changes in lipid polymorphism of model membranes. Chem
Phys Lipids 154(2):120–128
Kiselev M, Lesieur P, Kisselev AM, Lombardo D, Aksenov V (2002)
Model of separated form factors for unilamellar vesicles. Appl
Phys A Mater Sci Process 74(Suppl):S1654–S1656
Kiselev MA, Zemlyanaya EV, Aswal VK, Neubert RHH (2006) What
can we learn about the lipid vesicle structure from the small-angle
neutron scattering experiment?. Eur Biophys J 35(6):477–493
Kline SR (2006) Reduction and analysis of sans and usans data using
igor pro. J Appl Crystallogr 39(6):895–900
Knoll W, Haas J, Stuhrmann HB, Fuldner HH, Vogel H, Sackmann E
(1981) Small-angle neutron scattering of aqueous dispersions of
lipids and lipid mixtures. a contrast variation study. J Appl
Crystallogr 14(3):191–202
Knoll W, Ibel K, Sackmann E (1981) Small-angle neutron scattering
study of lipid phase diagrams by the contrast variation method.
Biochemisitry 20(22):6379–6383
Koukoulitsa C, Kyrikou I, Demetzos C, Mavromoustakos T (2006)
The role of the anticancer drug vinorelbine in lipid bilayers using
differential scanning calorimetry and molecular modeling. Chem
Phys Lipids 144(1):85–95
Kucerka N, Nagle JF, Sachs JN, Feller SE, Pencer J, Jackson A,
Katsaras J (2008) Lipid bilayer structure determined by the
simultaneous analysis of neutron and X-ray scattering data.
Biophys J 95(5):2356–2367
Kucerka N, Nieh M, Katsaras J (2009) Asymmetric distribution of
cholesterol in unilamellar vesicles of monounsaturated phospho-
lipids. Langmuir ACS J Surf Colloids 25(23):13522–13527
Kucˇerka N, Nieh M, Pencer J, Harroun T (2007) The study of
liposomes, lamellae and membranes using neutrons and X-rays.
Curr Opin Colloid Interf Sci 12:17–22
Kucerka N, Pencer J, Sachs JN, Nagle JF, Katsaras J (2007) Curvature
effect on the structure of phospholipid bilayers. Langmuir
23(3):1292–1299
Kurdi M, DeMello Walmor C, Booz George W (2005) Working
outside the system: an update on the unconventional behavior of
the renin-angiotensin system components. Int J Biochem Cell
Biol 37(7):1357–1367
Labinjoh C, Newby DE, Dawson P, Johnston NR, Ludlam CA, Boon
NA, Webb DJ (2000) Fibrinolytic actions of intra-arterial
angiotensin ii and bradykinin in vivo in man. Cardiovasc Res
47(4):707–714
Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R,
Guillemette G (2002) A polyaromatic caveolin-binding-like
motif in the cytoplasmic tail of the type 1 receptor for
angiotensin ii plays an important role in receptor trafficking
and signaling. Endocrinology 143(12):4702–4710
Lowe BM, Smith DG (1973) Glass electrode measurements in
deuterium oxide. Analy Lett 6(10):903–907
Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW
(1996) Membrane pores induced by magainin. Biochem Cell
Biol 35(43):13723–13728
Lundquist A, Wessman P, Rennie Adrian R, Edwards K (2008)
Melittin-lipid interaction: a comparative study using liposomes,
micelles and bilayer disks. Biochim Biophys Acta 1778(10):
2210–2216
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott
R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke,
and coronary heart disease. Part 1, prolonged differences in
blood pressure: prospective observational studies corrected for
the regression dilution bias. Lancet 335(8692):765–774
Mariani P, Casadio R, Carsughi F, Ceretti M, Rustichelli F (1997)
Structural analysis of membranes from photosynthetic bacteria
by sans. Europhys Lett 37(6):433–438
Mason PC, Gaulin BD, Epand RM, Wignall GD, Lin JS (1999) Small
angle neutron scattering and calorimetric studies of large
unilamellar vesicles of the phospholipid dipalmitoylphosphati-
dylcholine. Phys Rev E 59(3):3361–3367
Mavromoustakos T, Theodoropoulou E, Dimitriou C, Matsoukas JM,
Panagiotopoulos D, Makriyannis A (1996) Interactions of
angiotensin ii with membranes using a combination of differen-
tial scanning calorimetry and 31p nmr spectroscopy. Lett Pept
Sci 3(4):175–180
Nagle JF, Tristram-Nagle S (2000) Structure of lipid bilayers.
Biochim Biophys Acta 1469(3):159–195
Nallet F, Laversanne R, Roux D (1993) Modeling X-ray or neutron-
scattering spectra of lyotropic lamellar phases—interplay
between form and structure factors. J Phys II 3(4):487–502
Neutel JM, Smith DHG, Weber MA (1999) Is high blood pressure a
late manifestation of the hypertension syndrome? Am J Hyper-
tens 12(12):215S–223S
NIH (2003) The seventh report of the joint national commitee on
prevention, detection, evaluation, and treatment of high blood
pressure. Technical report, US Department of health and human
services
Pabst G, Grage S, Dannerpongratz S, Jing W, Ulrich A, Watts A,
Lohner K, Hickel A (2008) Membrane thickening by the
antimicrobial peptide pgla. Biophys J 95(12):5779–5788
Pachori AS, Huentelman MJ, Francis SC, Gelband CH, Katovich MJ,
Raizada MK (2001) The future of hypertension therapy: sense,
antisense, or nonsense?. Hypertens Res 37(2 Part 2):357–364
Pencer J, Hallett FR (2000) Small-angle neutron scattering from large
unilamellar vesicles: an improved method for membrane thick-
ness determination. Phys Rev E Stat Phys Plasmas Fluids Relat
Interdiscip Topics 61(3):3003–3008
Pencer J, Mills T, Anghel V, Krueger S, Epand RM, Katsaras J (2005)
Detection of submicron-sized raft-like domains in membranes by
small-angle neutron scattering. Euro Phys J E Soft Matter
18(4):447–458
Pencer J, Nieh M, Harroun TA, Krueger S, Adams C, Katsaras J
(2005) Bilayer thickness and thermal response of dimyristoyl-
phosphatidylcholine unilamellar vesicles containing cholesterol,
ergosterol and lanosterol: a small-angle neutron scattering study.
Biochim Biophys Acta 1720(1–2):84–91
Petoukhov MV, Svergun DI (2006) Joint use of small-angle X-ray and
neutron scattering to study biological macromolecules in solu-
tion. Euro Biophys J 35(7):567–576
Ruiz-Ortega M, Ruperez M, Esteban V, Egido J (2003) Molecular
mechanisms of angiotensin ii-induced vascular injury. Curr
Hypertens Rep 5(1):73–79
Schmiedel H, Almasy L, Klose G (2006) Multilamellarity, structure
and hydration of extruded popc vesicles by sans. Euro Biophys J
Biophy 35(3):181–189
Eur Biophys J (2011) 40:687–698 697
123
Seto GWJ, Marwaha S, Kobewka DM, Lewis RNAH, Separovic F,
McElhaney RN (2007) Interactions of the australian tree frog
antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1
with lipid model membranes: differential scanning calorimetric
and fourier transform infrared spectroscopic studies. Bba-
Biomembranes 1768(11):2787–2800
Severcan F, Sahin I, Kazanc N (2005) Melatonin strongly interacts
with zwitterionic model membranes—evidence from fourier
transform infrared spectroscopy and differential scanning calo-
rimetry. Bba-Biomembranes 1668(2):215–222
Shin YA, Yoo S (1996) Conformational study of angiotensin ii.
Biopolymers 38(2):183–190
Striker Gary E, Praddaude F, Alcazar O, Cousins Scott W, Marin-
Castano Maria E (2008) Regulation of angiotensin ii receptors
and extracellular matrix turnover in human retinal pigment
epithelium: role of angiotensin ii. Am J Physiol-Cell Ph
295(6):C1633–C1646
Stuhrmann HB, Burkhardt N, Dietrich G, Ju¨nemann R, Meer-
winck W, Schmitt M, Wadzack J, Willumeit R, Zhao J,
Nierhaus KH (1995) Proton-and deuteron spin targets in
biological structure research. Nucl Inst Methods Phys Res A
356:124–132
Surewicz WK, Mantsch HH (1988) Conformational properties of
angiotensin-ii in aqueous-solution and in a lipid environment—a
fourier-transform infrared spectroscopic investigation. J Am
Chem Soc 110(13):4412–4414
Svergun DI, Koch MHJ (2003) Small-angle scattering studies of
biological macromolecules in solution. Reports Progress Phys
66(10):1735–1782
Taylor WR (1999) Hypertensive vascular disease and inflammation:
mechanical and humoral mechanisms. Curr Hypertens Rep
1(1):96–101
Tung S, Lee H, Raghavan SR (2008) A facile route for creating
‘‘reverse’’ vesicles: insights into ‘‘reverse’’ self-assembly in
organic liquids. J Am Chem Soc 130(27):8813–8817
Valensin G, Delfini M, Gaggelli E (1986) Selective 1h-nmr relaxation
investigations of membrane-bound drugs in vitro. 2. angiotensin
ii. Biophys Chem 24(1):25–31
Wang Y, Qiu D, Cosgrove T, Denbow ML (2009) A small-angle
neutron scattering and rheology study of the composite of
chitosan and gelatin. Colloids Surf B Biointerf 70(2):254–258
Westh P (2009) Experimental approaches to membrane thermody-
namics. Soft Matter 5(17):3249–3257
WHO (2003) Diet, nutrition and the prevention of chronic diseases.
Technical report, World Health Organization
Winter R (2002) Synchrotron X-ray and neutron small-angle
scattering of lyotropic lipid mesophases, model biomembranes
and proteins in solution at high pressure. Biochimica et Biophysica
Acta (BBA)/Protein Struct Mol Enzymol 1595(1–2):160–184
Wyse BD, Prior IA, Qian H, Morrow IC, Nixon Susan, Muncke
Cornelia, Kurzchalia Teymuras V, Thomas Walter G, Parton
Robert G, Hancock John F (2003) Caveolin interacts with the
angiotensin ii type 1 receptor during exocytic transport but not at
the plasma membrane. J Biol Chem 278(26):23738–23746
Zoumpoulakis P, Daliani I, Zervou M, Kyrikou I, Siapi E, Lamprin-
idis G, Mikros E, Mavromoustakos T (2003) Losartan’s molec-
ular basis of interaction with membranes and at1 receptor. Chem
Phys Lipids 125(1):13–25
698 Eur Biophys J (2011) 40:687–698
123
